The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).

Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!

Resource Search

Search Results

Integrating End-User Research in MPT Product Development & Commercialization Strategies

Integrating End-User Research in MPT Product Development & Commercialization Strategies

The IMPT, Moushira El-Sahn, Andrea Thurman, Liz Pinto, Karina Fedasz May 2022
A Thought Paper on Fostering Greater Utilization of Social and Behavioural Research in The Development Setting and Creating Impact

A Thought Paper on Fostering Greater Utilization of Social and Behavioural Research in The Development Setting and Creating Impact

Moushira El-Sahn, Jeff Lucas and Stephen Godwin, with Foreward by Joe Romano, NWJ Group Visit Reports May 2022
Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER Study

Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER Study

Michael A. Thomas, MD, Robert Morlock, PhD, Clint Dart, MS, and Brandon Howard, PhD Visit Journal Article March 2022
MPT Regulatory Pathways: Case Studies From MPT Product Developers

MPT Regulatory Pathways: Case Studies From MPT Product Developers

The IMPT, Mary Weitzel, Daniel Loeven, Wilberto Robles February 2022
Glossary of Regulatory Terms

Glossary of Regulatory Terms

Glossary of Regulatory Terms Feb 2022 click to view Guidance Document In this Technical Brief: Topic(s): Regulatory Terms Glossary Region(s): United States

Word on the Street: African Women Share Their Reproductive Health Stories

Word on the Street: African Women Share Their Reproductive Health Stories

Developed by CAMI Health, Wits RHI, and FHI360. February 2022
Inactive Ingredient Search for Approved Drug Products

Inactive Ingredient Search for Approved Drug Products

Inactive Ingredient Search for Approved Drug Products January 2022 click to view Guidance Document In this Technical Brief: Product Type(s): Drug Products Topic(s): Inactive Ingredients Region(s): United States

Visit Webpage January 2022
Principles of Premarket Pathways for Combination Products

Principles of Premarket Pathways for Combination Products

Principles of Premarket Pathways for Combination Products – Guidance for Industry and FDA Staff January 2022 click to view Guidance Document In this Technical Brief: Health Risk(s): Combination Products Product Type(s): Combination Topic(s): Regulatory Issues Region(s): United States

Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, Center for Drug Evaluation and Research Office of the Commissioner, Office of Clinical Policy and Programs, Office of Combination Products Visit Guidance Document January 2022
Medicines Patent Pool: Long-Acting Therapeutics

Medicines Patent Pool: Long-Acting Therapeutics

Medicines Patent Pool: Long-Acting Therapeutics December 2021 click to view Webpage In this Technical Brief: Product Type(s): Long-Acting Therapeutics Topic(s): Expanding Access to Long-acting Therapeutics in LMICs Region(s): United States, L/MICs

Lobna Gaayeb, Long-Acting Technologies Project Manager Visit Webpage December 2021
Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries

Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries

Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries View Report December, 2021 In this Report: Topic(s): Multipurpose Prevention Technology Pipeline Landscape

Young Holt, Bethany; Moore, Susanna; Romano, Joseph; van der Straten, Ariane Visit Reports December 2021
Introducing New Contraceptive Options: Product Registration Basics for Global Health Program Managers

Introducing New Contraceptive Options: Product Registration Basics for Global Health Program Managers

Introducing New Contraceptive Options: Product Registration Basics for Global Health Program Managers In this Report: Topic(s): Regulatory Pathways Global Health Contraception

Robles, Wilberto; Magubane, Noxolo; Jackson, Ashley; Harris, Danielle; Stachowski, Courtney Visit Technical Brief December 2021
Advancing Self-Care with Multipurpose Prevention Technologies (MPTs)

Advancing Self-Care with Multipurpose Prevention Technologies (MPTs)

Featured in the CTI Exchange’s Beginning with the End in Mind series, CAMI Health joins the nuanced conversation surrounding self-care within the sexual and reproductive health domain by highlighting the unique contributions and benefits of multipurpose prevention technologies (MPTs).

Langrin, Madison; Rubens, Hannah; CAMI Health Visit Blog November 2021

Annual National Reproductive Health Conference

10-13 August 2021 Annual National Reproductive Health Conference San Francisco, CA, USA

Visit Convening August 2021
Giving Voice to the End-User: Input on Multipurpose Prevention Technologies From the Perspectives of Young Women in Kenya and South Africa

Giving Voice to the End-User: Input on Multipurpose Prevention Technologies From the Perspectives of Young Women in Kenya and South Africa

Minnis, A.; Krogstad, E.; Shapley-Quinn, M.K.; Agot, K.; Ahmed, K.; & Wagner, L.D. July 2021
Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review

Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review

Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review July, 2021 click to view Report In this Report: Topic(s): Compounds with Multiple Potential Activities

Young Holt, Bethany; Moore, Susanna; Yang, Katherine; Hemmerling, Anke Visit Technical Brief July 2021
Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

Lorna Begg, Rebecca Brodsky, Barbara Friedland, Sanyukta Mathur, Jim Sailer, George Creasy Visit Journal Article July 2021
MPT Mini Video Series

MPT Mini Video Series

The IMPT introduces its MPT Mini Video Series, a new audiovisual project aimed to raise awareness about MPTs and bring digestible bits of the MPT story to your fingertips. The series kicks off with an introduction to the first-ever MPT in “King Minos & the First Condom.” In the second video, “If I Could Talk to the Scientists…”, we hear first-hand from health professionals at Wits RHI on the potential of MPTs to improve sexual and reproductive health. Stay tuned for upcoming videos in the series bringing you more voices from women around the world.

CAMI Health Visit Video / Radio July 2021
Opportunities and Challenges for MPT & HIV Prevention Drug Delivery Approaches

Opportunities and Challenges for MPT & HIV Prevention Drug Delivery Approaches

The IMPT, Rahima Benhabbour, Courtney Jarrahian, Joseph Romano June 2021
New Frontiers in STI/HIV Prevention & Family Planning: The Promise of Multipurpose Prevention Technologies

New Frontiers in STI/HIV Prevention & Family Planning: The Promise of Multipurpose Prevention Technologies

The IMPT, California Prevention Training Center (CAPTC), Dr. Ina Park, Dr. Bethany Young Holt June 2021
Combining Active Pharmaceutical Ingredients: MPT Development & Regulatory Considerations

Combining Active Pharmaceutical Ingredients: MPT Development & Regulatory Considerations

The IMPT, Certara, Deven Shah, Kevin Hershberger, Tamra Goodrow June 2021
Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe

Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe

Alejandro J. Paredes, Inken K. Ramöller, Peter E., McKenna, Marco T.A. Abbate, Fabiana Volpe-Zanutto, Lalitkumar K.Vora, Maggie Kilbourne-Brook, Courtney Jarrahian, Kurtis Moffatt, Chunyang Zhang, Ismaiel A. Tekko, Ryan F. Donnelly June 2021
MPTs & the IMPT Platform

MPTs & the IMPT Platform

MPTs & the IMPT Platform May 2021 The MPTs & the IMPT Platform is a PowerPoint presentation created by the IMPT Secretariat at CAMI Health to help our colleagues integrate MPTs into their talks and presentations. Please email IMPT@cami-health.org with any feedback on how you used this information. Download the presentation slide deck CAMI Health […]

IMPT, CAMI Health May 2021
Toxicity study considerations for HIV prevention and MPT R&D

Toxicity study considerations for HIV prevention and MPT R&D

The IMPT, Thomas Moench, Miles Brennan May 2021
Advocates’ Guide to Multipurpose Prevention Technologies

Advocates’ Guide to Multipurpose Prevention Technologies

AIDS Vaccine Advocacy Coalition (AVAC) May 2021
The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy

The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy

The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy The IMPT’s Susanna Moore, Bethany Young Holt, and IMPT Advisory Council Member Thesla Palanee-Philips of Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, presented an introductory MPT panel at USAID’s Global Health Science and Practice Technical Exchange (GHTechX) in […]

The IMPT, Wits RHI, Susanna Moore, Bethany Young Holt, Thesla Palanee-Philips April 2021
Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned

Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned

The IMPT, Deborah Anderson, Mary Weitzel, Betsy Tolley, Matthew Quaife, Khatija Ahmed, Joseph Murungu, Bethany Young Holt March 2021
TRIO Study Brief:  Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

TRIO Study Brief: Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

RTI International | Women’s Global Health Imperative; Impact Research and Development Organization, Kenya; Setshaba Research Centre, South Africa; The Initiative for MPTs (IMPT) February 2021
Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial

Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial

Joseph A. Politch; Susan Cu-Uvin; Thomas R. Moench; Karen T. Tashima; Jai G. Marathe; Kate M. Guthrie; Howard Cabral; Tara Nyhuis; Miles Brennan; Larry Zeitlin; Hans M. L. Spiegel; Kenneth H. Mayer; Kevin J. Whaley; Deborah J. Anderson February 2021
Microbicide Trials Network (MTN) Socio-behavioral Research Compendium

Microbicide Trials Network (MTN) Socio-behavioral Research Compendium

Microbicide Trials Network (MTN) Behavioral Research Working Group (BRWG) January 2021
Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women

Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women

Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women January, 2021 Recent results from long-acting HIV prevention trials in parallel with the MPTs in the pipeline herald an exciting time for the MPT field. However, given finite resources and technical challenges to advance products from preclinical […]

Bethany Young Holt, Susanna Moore, Anke Hemmerling, Kavita Nanda, Greg Kopf, Thesla Palanee-Phillips, Sharon L. Achilles January 2021
The role of cervicovaginal microbiota on contraceptive and MPT development

The role of cervicovaginal microbiota on contraceptive and MPT development

The IMPT, Jacques Ravel, Jennifer Deese December 2020
Donation  of  Contraceptive  Products  through  Special  Import  Permits:  A  Case Study in Zambia and Nigeria

Donation of Contraceptive Products through Special Import Permits: A Case Study in Zambia and Nigeria

Donation of Contraceptive Products through Special Import Permits: A Case Study in Zambia and Nigeria December 2020 click to view Guidance Document In this Technical Brief: Topic(s): Contraceptive Products Special Import Permits Region(s): Zambia Nigeria

Courtney Stachowski, Noxolo Magubane, Mbavhalelo Jade Tshikosi, Wilberto Robles Visit Journal Article December 2020
Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”

Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”

Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process” September 2020 click to view Guidance Document In this Technical Brief: Product Type(s): Medical Devices Topic(s): Product Development Regulatory Issues Region(s): United States

U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation and Research Visit Guidance Document September 2020
23rd International AIDS Conference (AIDS 2020: Virtual)

23rd International AIDS Conference (AIDS 2020: Virtual)

International AIDS Society (IAS) July 2020
A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial

A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial

Thomas, M.; Chappell, B.T.; Maximos, B.; Cullwell, K.; & Howard, B. July 2020
Sexual and Reproductive Health Research and Development: Understanding the Spectrum

Sexual and Reproductive Health Research and Development: Understanding the Spectrum

Sexual and Reproductive Health Research and Development: Understanding the Spectrum 2020 G-Finder click to view Report In this Report: Topic(s): Funding landscape of MPTs

Dr Nick Chapman Anna Doubell Maya Goldstein Dr Paul Barnsley Lisette Oversteegen Dr Vipul Chowdhary Dr George Rugarabamu Juliette Borri Dr Amelia Hynen Ming Ong Dr Iona Tjoeng Madeleine Kearney Visit Report July 2020
Assessment Report Dapivirine Vaginal Ring 25 mg

Assessment Report Dapivirine Vaginal Ring 25 mg

Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMA) July 2020
Bridging the gap: Advancing multipurpose prevention technologies from the lab into the hands of women

Bridging the gap: Advancing multipurpose prevention technologies from the lab into the hands of women

Young Holt, B., Kiarie, J., Kopf, G., Nanda, K., Hemmerling, A., & Achilles, S. May 2020
ISO 14971: 2019 — Medical devices: Application of risk management to medical devices

ISO 14971: 2019 — Medical devices: Application of risk management to medical devices

Medical devices: Application of risk management to medical devices   December 2019 click to view Guidance Document In this Technical Brief:     Product Type(s): Medical Devices Topic(s): Regulatory Issues Region(s): United States